It's anticipated that they will be announced before month's end. Afandin's exclusivity agreement expires around the end of the month with regards to ATL1101 so we will hear something about this, the announcement in February with regards to TJAB and ATL1102 mentioned that they expect to reach agreement before 30 June however both parties were hopeful to do it sooner, and ATL1103 has been mentioned that they are in discussion with regards to phase II trials and expect to be in a position to announce an update by end June.
Where ATL1103 is concerned, if they do reach an agreement, I imagine it will be similar to ISIS/Biogen deal at the beginning of the year as they were in the development stage and that involved a $29m upfront and ISIS had an option to commercialise on successful p2/3 trials. So if a deal isn't done, I would expect that it is because the pharma wasn't prepared to make a similar deal. With the other two though, I'm not sure as to what the deal could potentially be, PeaceAKKI has previously indicated though that they would expect it to only be a mill or two.
- Forums
- ASX - By Stock
- PER
- get real
get real , page-14
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.001(1.01%) |
Mkt cap ! $90.15M |
Open | High | Low | Value | Volume |
10.5¢ | 10.8¢ | 10.0¢ | $85.75K | 839.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 816255 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 275536 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 816255 | 0.100 |
3 | 203188 | 0.099 |
2 | 108491 | 0.098 |
2 | 31927 | 0.097 |
2 | 25004 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 275536 | 3 |
0.110 | 284063 | 5 |
0.115 | 593850 | 6 |
0.120 | 310642 | 8 |
0.125 | 110429 | 2 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online